Increased ECV fraction correlates strongly with histologically quantified myocardial fibrosis👉leading to cardiomyopathy (which is a leading cause of death in individuals with #SickleCell disease).
We used Cardiac MRI to study the individuals with #SickleCell disease who started disease-modifying therapy early in childhood vs later. We found no differences in the ECV (aka myocardial fibrosis) @BloodJournalsciencedirect.com/science/articl…
Even more concerning is that diffuse myocardial fibrosis is nearly universal in children and young adults with #SickleCell disease, even those patients with normal cardiac size and function.
Our findings suggest that damage to the myocardium occurs before symptoms or clinical markers of cardiac dysfunction and that our current screening protocols may require revision to include earlier cardiac assessments. #SickleCell#StartScreeningEarlysciencedirect.com/science/articl…
#TCTM21 Significantly worse EFS and higher incidence of graft failure among #SickleCell disease patients undergoing #BMTsm on Medicaid compared to private insurance - Very important study from @CIBMTR by Tatenda Geraldine Mupfudze and colleagues tct.confex.com/tct/2021/meeti…
Similar trend in #BMTsm utilization in adult acute leukemia patients’ - public insurance, race and older age has significant influence on #HCT utilization, abstract by Silas Day #TCTM21tct.confex.com/tct/2021/meeti…
#TCTM21 Naseem Esteghamat identified disparities in auto #HCT utilization, specifically among African Americans vs Whites (OR: 0.68), patients covered on Medicare or Medicaid vs private insurance (OR: 0.79), and those with lower SES (OR: 0.71). tct.confex.com/tct/2021/meeti…
While there have been close to 100,000 papers related to COVID-19 listed on @NCBI@NLM_NIH#Pubmed, there are very few that address outcomes after #COVID19 in #BMTsm patients, a few are listed in the next tweet: 2/